CID 60919

Tasosartan

Structural Information

Molecular Formula
C23H21N7O
SMILES
CC1=C2CCC(=O)N(C2=NC(=N1)C)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
InChI
InChI=1S/C23H21N7O/c1-14-18-11-12-21(31)30(23(18)25-15(2)24-14)13-16-7-9-17(10-8-16)19-5-3-4-6-20(19)22-26-28-29-27-22/h3-10H,11-13H2,1-2H3,(H,26,27,28,29)
InChIKey
ADXGNEYLLLSOAR-UHFFFAOYSA-N
Compound name
2,4-dimethyl-8-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-5,6-dihydropyrido[2,3-d]pyrimidin-7-one
Related CIDs

2D Structure

compound 2d structure
5
Annotation Hits

29
References

16621
Patents

411.18076 Da
Monoisotopic Mass

3.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 412.18804 206.7
[M+Na]+ 434.16998 216.0
[M-H]- 410.17348 210.4
[M+NH4]+ 429.21458 208.9
[M+K]+ 450.14392 205.3
[M+H-H2O]+ 394.17802 192.0
[M+HCOO]- 456.17896 216.7
[M+CH3COO]- 470.19461 212.7
[M+Na-2H]- 432.15543 206.7
[M]+ 411.18021 204.5
[M]- 411.18131 204.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe